It's time for our final stock versus stat.
We're pitting the stock of UnitedHealth Group--which trades under the ticker UNH--up against the stats of Houston Texans quarterback Deshaun Watson.
UnitedHealth is a holding in Jim Cramer's Action Alerts PLUS portfolio.
The stock is currently trading around $293.
"The stock is way overbought. I own it for the charitable trust," noted Cramer.
“Additionally, we think investor sentiment will materially improve in 2020 with Democratic Presidential candidates opposed to Medicare-for-All winning each of the first four state contests in IA, NH, NV and SC, where they currently lead Medicare-for-All candidates based on the latest FiveThirtyEight polling averages,” wrote Colin Scarola of CFRA research.
But how's UNH looking in the long-run?
"The biggest headline takeaway thus far has been the financial projections for 2020. Management expects the company to end fiscal 2019 with $15 per share earnings on $242 billion in revenue. Next year, revenue will increase to a range of $260-$262 billion with adjusted net earnings of $16.25-$16.55 per share. This compares to current estimates of $260.82 billion in revenue and earnings per share of $16.46. I suppose we can call those numbers in line with expectations, but the potential for big upside on the bottom line appears muted," wrote Real Money's Tim Collins in early December.
Both Cramer and Bill Enright, co-host of BMF, went with Watson.
So, who would you pick -- Watson or the stock of UNH?